NCT04576325
- Conditions
- Aspergillosis, Asthma, Bacterial Infections and Mycoses, +16 more
- Locations
-
- Q-Pharm Pty Ltd (Nucleus Networks) Brisbane, Queensland, Australia
Clinical trial condition
Explore clinical trials studying Aspergillosis. Study availability and eligibility vary by location and protocol.
NCT04576325
NCT03920527
NCT03471988
NCT04872231
NCT04368221
NCT02180165
Not specified
NCT03641131
NCT01533558
NCT04431804